Hypertrophic cardiomyopathy trials in Germany

In Germany 11 Also abroad 88

11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
Where
Bad Oeynhausen, Goettingen, Heidelberg, Jena
Age
18 years and over
People
130 worldwide
Run by
Imbria Pharmaceuticals Inc.
See details and how to join2024-515125-28-00 · EU 2024-515125-28-00
No phaseEnrolling by invitation
Focal Pulsed Field Ablation of Ventricular Tachycardia
Where
Wismar
Age
18 years and over
People
100
Run by
Sana Hanse Hospital Wismar
See details and how to joinNCT07929545
Phase 2Taking people
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Where
Bad Oeynhausen, Göttingen, Heidelberg, Jena
Age
18 years and over
People
165 worldwide
Run by
Imbria Pharmaceuticals, Inc.
See details and how to joinNCT07023614
Phase 2/3Enrolling by invitation
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
Where
Bad Nauheim, Berlin, Essen, Goettingen, Heidelberg, Jena, Wuerzburg
Age
18 years to 85 years
People
900 worldwide
Run by
Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00
Phase 2Taking people
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Where
Munich
Age
8 years and over
People
18 worldwide
Run by
Rocket Pharmaceuticals Inc.
See details and how to joinNCT06092034
No phaseTaking people
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Where
Aalen, Berlin, Bernau, Dresden, Erlangen, Leipzig, Münster
Age
18 years and over
People
1,700 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05489705
No phaseTaking people
Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)
Where
München
People
100
Run by
Deutsches Herzzentrum Muenchen
See details and how to joinNCT07344480
No phaseTaking people
Multimodal Analysis of Endomyocardial Biopsies
Where
Essen
Age
18 years and over
People
216
Run by
University Hospital, Essen
See details and how to joinNCT07359690
No phaseTaking people
Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy
Where
Munich
Age
18 years to 99 years
People
24
Run by
Technical University of Munich
See details and how to joinNCT07077005
No phaseTaking people
DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
Where
Heidelberg
Age
18 years to 80 years
People
2,040
Run by
University Hospital Heidelberg
See details and how to joinNCT04265040
No phaseTaking people
Evaluation of HEArt invoLvement in Patients With FABRY Disease
Where
Würzburg
Age
18 years and over
People
650
Run by
Wuerzburg University Hospital
See details and how to joinNCT03362164